Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Federica SoràDepartment of Hematology, Catholic University of Sacred Heart, Rome, Italy;

Francesca Romana PonzianiDepartment of Internal Medicine and Gastroenterology, Catholic University of Sacred Heart, Rome, Italy

Luca LaurentiDepartment of Hematology, Catholic University of Sacred Heart, Rome, Italy;

Patrizia ChiusoloDepartment of Hematology, Catholic University of Sacred Heart, Rome, Italy;

Francesco AutoreDepartment of Hematology, Catholic University of Sacred Heart, Rome, Italy;

Antonio GasbarriniDepartment of Internal Medicine and Gastroenterology, Catholic University of Sacred Heart, Rome, Italy

Simona SicaDepartment of Hematology, Catholic University of Sacred Heart, Rome, Italy;

Maurizio PompiliDepartment of Internal Medicine and Gastroenterology, Catholic University of Sacred Heart, Rome, ItalyCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgement

The study has been supported by Centro di ricerca sulle cellule staminali emopoietiche e sulle terapie cellulari, Catholic University of the Sacred Heart, Rome.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2016.1219906.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Information for

Open access

Opportunities

Help and information

Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors

Acknowledgement

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature